Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: MaryinRed who wrote (17861)	3/6/1999 11:47:00 PM
From: RockyBalboa	Respond to of 122087

about PDCI (D).... and W S P N Message 7630283 techstocks.com Message 8179603 Message 8180511 I frequently received PDCID spam emails, also one with WSPN (of the same layout..same source???) For the 20 day window, it traded as PDCID because of the 1:40 reverst stock split. C.

To: MaryinRed who wrote (17861)	3/7/1999 12:12:00 AM
From: Nazbuster	Read Replies (1) \| Respond to of 122087

Mary, I got the following in my email so IT MUST BE GOOD ADVICE! Do you think I should mortgage my home and back up the truck for this one? Subject: RE: BIOTECH BREAKTHROUGH! Date: Sat, 06 Mar 99 22:07:07 EST From: marketwin@sdm.net.mx To: mrpark@sdm.net.mx Company: Endovasc Ltd., Inc. Symbol: E N D V Price: 1/2 ($.50/share) The April issue of the British Biotechnology Letter, Oxford, England,states "scientists at Glaxo Wellcome have proven the efficacy of Endovasc's PGE-1 and have submitted to management a multi-million dollar joint venture proposal". ENDV is recommended as an immediate and "STRONG BUY". go to: quote.yahoo.com P.S. Don't bother writing to the email address... every one of these I've ever received has a phony address. LOL!